Autopsy Proven Pulmonary Mucormycosis Due to
COVID-19
co-infections
fungal infections
mucormycosis
Journal
Journal of fungi (Basel, Switzerland)
ISSN: 2309-608X
Titre abrégé: J Fungi (Basel)
Pays: Switzerland
ID NLM: 101671827
Informations de publication
Date de publication:
27 Jan 2021
27 Jan 2021
Historique:
received:
27
11
2020
revised:
23
12
2020
accepted:
25
01
2021
entrez:
30
1
2021
pubmed:
31
1
2021
medline:
31
1
2021
Statut:
epublish
Résumé
Viral infections can cause acute respiratory distress syndrome (ARDS), consequently leading to susceptibility for secondary pulmonary infections. Over the past few weeks, a number of studies have reported on secondary pulmonary aspergillosis complicating severe COVID-19. We report the case of a 53-year old male patient with secondary acute myeloid leukemia (AML) who suffered from COVID-19 ARDS and was diagnosed postmortem with mucormycosis.
Identifiants
pubmed: 33513875
pii: jof7020088
doi: 10.3390/jof7020088
pmc: PMC7912223
pii:
doi:
Types de publication
Case Reports
Langues
eng
Références
JAMA. 2020 Apr 7;323(13):1239-1242
pubmed: 32091533
Cureus. 2020 Sep 30;12(9):e10726
pubmed: 33145132
Am J Emerg Med. 2020 Sep 16;:
pubmed: 32972795
Clin Infect Dis. 2020 Aug 29;:
pubmed: 32860682
J Fungi (Basel). 2020 Jun 30;6(3):
pubmed: 32630111
J Fungi (Basel). 2020 Jun 24;6(2):
pubmed: 32599813
Clin Infect Dis. 2020 Sep 05;:
pubmed: 32887998
Clin Infect Dis. 2020 Oct 30;:
pubmed: 33124650
Lancet Infect Dis. 2019 Dec;19(12):e405-e421
pubmed: 31699664